503 related articles for article (PubMed ID: 11191119)
21. [Modern treatment of acute myocardial infarction without ST elevation].
Butt N; Kuiper KK; Nordrehaug JE
Tidsskr Nor Laegeforen; 2004 Mar; 124(5):644-7. PubMed ID: 15004610
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological treatment of acute coronary syndromes.
Hughes K
Prof Nurse; 2003 Jan; 18(5):296-9. PubMed ID: 12599964
[TBL] [Abstract][Full Text] [Related]
23. Antiplatelet therapy in patients with unstable angina and non-ST-segment-elevation myocardial infarction: findings from the CRUSADE national quality improvement initiative.
Bottorff MB; Nutescu EA; Spinler S
Pharmacotherapy; 2007 Aug; 27(8):1145-62. PubMed ID: 17655514
[TBL] [Abstract][Full Text] [Related]
24. [Acute coronary syndromes with ST-segment elevation: fibrinolytic therapy].
Cuccia C
Ital Heart J; 2003 Dec; 4 Suppl 8():9S-15S. PubMed ID: 15005523
[No Abstract] [Full Text] [Related]
25. Management of unstable angina and non-ST-segment elevation myocardial infarction.
Hanley HG; Nylk TM; Nguyen N
J La State Med Soc; 2001 Jun; 153(6):306-11. PubMed ID: 11480381
[TBL] [Abstract][Full Text] [Related]
26. Effects of glycoprotein IIb/IIIa inhibition on clinical stabilization parameters in patients with unstable angina and non-Q-wave myocardial infarction.
Okmen E; Cakmak M; Tartan Z; Cam N
Heart Vessels; 2003 Jul; 18(3):117-22. PubMed ID: 12955426
[TBL] [Abstract][Full Text] [Related]
27. [Two year follow-up of acute ischemic syndrome without ST elevation].
Tan HQ; Zhu J; Liang Y; Zhang Y; Liu LS;
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):184-8. PubMed ID: 15854465
[TBL] [Abstract][Full Text] [Related]
28. Antithrombotic therapy and the transition to the catheterization laboratory in UA/NSTEMI.
Ferguson JJ; Wilson JM; Diez J
Minerva Cardioangiol; 2007 Oct; 55(5):529-56. PubMed ID: 17912162
[TBL] [Abstract][Full Text] [Related]
29. Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry.
Lim MJ; Spencer FA; Gore JM; Dabbous OH; Agnelli G; Kline-Rogers EM; Dibenedetto D; Eagle KA; Mehta RH;
Eur Heart J; 2005 Jun; 26(11):1063-9. PubMed ID: 15716281
[TBL] [Abstract][Full Text] [Related]
30. Low-molecular-weight heparins for the treatment of acute coronary syndromes.
Wong GC; Giugliano RP
Semin Vasc Med; 2003 Nov; 3(4):391-402. PubMed ID: 15199446
[TBL] [Abstract][Full Text] [Related]
31. Advances in antiplatelet therapy for ACS and PCI.
Moliterno DJ
J Interv Cardiol; 2008 Dec; 21 Suppl 1():S18-24. PubMed ID: 19090933
[TBL] [Abstract][Full Text] [Related]
32. [Current use of anti-hemostatics in ischemic cardiopathy].
Bolao IG; Alegría E; Iglesias I; Velasco S; Fidalgo ML; Gómez JA; Huelmos A
Rev Med Univ Navarra; 1990; 34(4):219-26. PubMed ID: 2152748
[TBL] [Abstract][Full Text] [Related]
33. An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS.
Morrow DA; Antman EM; Snapinn SM; McCabe CH; Theroux P; Braunwald E
Eur Heart J; 2002 Feb; 23(3):223-9. PubMed ID: 11792137
[TBL] [Abstract][Full Text] [Related]
34. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38).
Wiviott SD; Antman EM; Gibson CM; Montalescot G; Riesmeyer J; Weerakkody G; Winters KJ; Warmke JW; McCabe CH; Braunwald E;
Am Heart J; 2006 Oct; 152(4):627-35. PubMed ID: 16996826
[TBL] [Abstract][Full Text] [Related]
36. Predictors and impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction.
Manoukian SV
Am J Cardiol; 2009 Sep; 104(5 Suppl):9C-15C. PubMed ID: 19695355
[TBL] [Abstract][Full Text] [Related]
37. The year in non-ST-segment elevation acute coronary syndromes.
Giugliano RP; Braunwald E
J Am Coll Cardiol; 2006 Jul; 48(2):386-95. PubMed ID: 16843191
[No Abstract] [Full Text] [Related]
38. Tirofiban in acute coronary syndromes.
Menozzi A; Merlini PA; Ardissino D
Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):193-206. PubMed ID: 15853593
[TBL] [Abstract][Full Text] [Related]
39. [Epidemiology of acute coronary syndromes in cardiology departments of the Emilia Romagna region: the AI-CARE2 study].
Pavesi PC; Ottani F; Bologna F; Gaddi O; Alboni P; Galvani M
Ital Heart J Suppl; 2003 Sep; 4(9):733-44. PubMed ID: 14635391
[TBL] [Abstract][Full Text] [Related]
40. [Strategies to improve reperfusion with fibrinolytic therapy in ST-T elevation myocardial infarction].
Jerjes-Sánchez C; Sosa del Angel E; García Sosa A; Reyes Cerezo E; Garza Ruiz A
Arch Cardiol Mex; 2003; 73(1):46-58. PubMed ID: 12820494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
